波士顿科学公司的股票暴涨了18.8%,因为它比收入估计值高,预测Q2增长强劲。 Boston Scientific's stock surged 18.8% as it beat earnings estimates and forecast strong Q2 growth.

波士顿科学公司是一家医疗设备公司,在第一季度,由于机构投资者Bancaire Privee联盟出售股票,其库存增加了18.8%,而红鹰财富顾问公司则增加了其持有量。 Boston Scientific, a medical devices company, saw its stock rise 18.8% in the first quarter as institutional investor Union Bancaire Privee sold shares, while Redhawk Wealth Advisors increased its holdings. 该公司报告的EPS为0.75美元,殴打估计数,现在预测Q2 EPS为0.710-0.730美元,收入为48亿至49亿美元。 The company reported EPS of $0.75, beating estimates, and now forecasts Q2 EPS of 0.710-0.730 and revenue of $4.8 billion-$4.9 billion. 它有“强势购买”评级,目标价格为116.00美元。 It has a "strong buy" rating and a target price of $116.00.